Cosmos Wisdom
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Cosmos Wisdom - overview
Established
2018
Location
Hangzhou, Zhejiang, China
Primary Industry
Healthcare
About
Established in 2018 and based in Hangzhou, China, Cosmos Wisdom operates as a diagnostic and treatment service dedicated to the early cancer screening in IVD (In vitro diagnostics) field. In 2022, it acquired the titles of Zhejiang Province Science and Technology Small and Medium Enterprises and the title of Hangzhou Unicorn Enterprise. The company owns intellectual property rights in China and the United States. Cosmos Wisdom cooperates with ThermoFisher Scientific, Shimadzu, and other companies.
In November 2020, it raised CNY 60 million in strategic investment from new investor ZH Capital. The company mainly provides immunity product series and microbial product series. Cosmos Wisdom uses proteomics, metabolomics, genomics and other technologies to develop products with early diagnosis functions for cancer. The company also provides biochemical immunity, microbiology laboratory, precision centre co-construction, medical testing laboratory and other solutions.
The company's products target lung cancer, gastric cancer, liver cancer and other high-incidence cancers.
Current Investors
ZH Capital, Cosmos Group Co., Ltd., Puhua Capital
Primary Industry
Healthcare
Sub Industries
Diagnostic, Medical & Imaging Laboratories, Oncology/Cancer Treatment
Website
www.cwmda.com
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.